KMTS Company Profile and Key Details

NASDAQ : KMTS

Kestra Medical Technologies

$19.82

-2.25-10.20%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kestra Medical Technologies, Ltd. (KMTS) stock declined over -10.19%, trading at $19.82 on NASDAQ, down from the previous close of $22.07. The stock opened at $21.52, fluctuating between $19.79 and $21.78 in the recent session.

Stock Snapshot

22.07

Prev. Close

1.16B

Market Cap

19.79

Day Low

-3.63

P/E Ratio

-5.46

EPS (TTM)

N/A

Cash Flow per Share

21.52

Open

58.37M

Number of Shares

21.78

Day High

46.53%

Free Float in %

N/A

Book Value

329.13K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 15, 2026	21.52	21.78	19.74	19.82	329.13K
May 14, 2026	21.61	22.37	21.18	22.07	250.95K
May 13, 2026	21.80	22.42	21.15	21.45	290.54K
May 12, 2026	21.84	22.37	20.58	21.57	244.86K
May 11, 2026	20.96	22.03	19.00	21.83	282.2K
May 08, 2026	21.42	21.58	20.95	21.05	211.97K
May 07, 2026	20.74	21.81	20.59	21.52	233.78K
May 06, 2026	20.32	21.95	19.00	20.71	389.82K
May 05, 2026	20.59	21.26	19.77	20.25	149.96K
May 04, 2026	21.82	22.40	20.25	20.55	319.15K
Apr 30, 2026	19.60	20.94	19.00	20.72	301.98K
Apr 29, 2026	21.44	22.07	19.49	19.51	209.45K
Apr 28, 2026	22.24	23.25	21.46	21.66	237.98K
Apr 27, 2026	22.43	23.03	21.95	22.23	176.32K
Apr 23, 2026	23.86	24.16	22.29	22.72	184.38K
Apr 22, 2026	23.60	24.52	23.31	23.81	296.09K
Apr 21, 2026	23.61	24.44	22.61	23.20	258.06K
Apr 20, 2026	22.75	24.12	21.81	23.31	412.39K
Apr 17, 2026	20.98	22.97	20.10	22.81	393.26K
Apr 16, 2026	20.25	20.76	19.82	20.41	213.8K

Contact Details

Kirkland, WA 98033

United States

https://kestramedical.com 425 279 8002

About Company

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Stock Peers

ATRI

0.26+0.06%

Atrion Corporation$459.92 ISRG

-6.94-1.62%

Intuitive Surgical, Inc.$421.12 MASI

0.12+0.07%

Masimo Corporation$178.47 ICUI

-4.27-3.47%

ICU Medical, Inc.$118.72 RGEN

-0.51-0.49%

Repligen Corporation$102.87 LMAT

-2.19-2.20%

LeMaitre Vascular, Inc.$97.31 HOLX

0.0000020.00%

Hologic, Inc.$76.01 UTMD

-0.36-0.57%

Utah Medical Products, Inc.$63.34 MMSI

-1.2-1.92%

Merit Medical Systems, Inc.$61.36 COO

-0.77-1.28%

The Cooper Companies, Inc.$59.61

Company Overview

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) closed at $19.82 USD, losing -$2.25 (-10.19%) from the previous close of $22.07. The stock is currently mid-range between its 52-week high and low $13.25 and $30.00. With a market capitalization of about $1.16 billion, Kestra Medical Technologies, Ltd. is classified as a small-cap and shows market-like volatility (beta ~0.83). Key stats such as the average daily volume over the past year has been around 354.97 thousand shares, in line with its 52-week average. Headquartered in Kirkland, WA, Kestra Medical Technologies, Ltd. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Brian Webster, the company employs approximately 300 people and listed since March 06, 2025. Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

Technical Performance

KMTS has shown weak momentum, losing -1.75% over the past week and -6.54% over the past quarter, though year-to-date performance is down -13.27%. Short-term trend indicators are bearishly aligned (SMA20 -5.47%, SMA50 -4.23%, SMA200 10.63%). The stock’s 14-day RSI is 41.88 (neutral), while the ATR of 1.65 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.17% below its high and over 85.28% above its low. Average 10-day trading volume of 279.16 thousand shares is below the 3-month average of 360.27 thousand, indicating normal recent market interest.

Valuation Metrics

Kestra Medical Technologies, Ltd. trades at a P/E ratio of -7.45, slightly below the S&P 500 average, with a price-to-sales ratio of 14.25 and a price-to-book ratio of 3.75 trading at moderately above to book value. The P/FCF stands at -9.94, also above market averages.

Dividend & Fair Value

Kestra Medical Technologies, Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$22.50. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 31.93% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 4 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $32.00 to $17.00. The high target offers 61.45% upside. The low target suggests -14.23% downside. The mean target is $28.33. This offers 42.94% upside. Kestra Medical Technologies, Ltd. earnings surprise history is a mixed track record. The quarter that ended March 17, 2026, missed forecasts by 2.32%. The prior quarter beat by 10.71%. Over the last six quarters, Apple has recorded several small beats. These include -30.3% in September 11, 2025.

Shareholding & Insider Activity

Kestra Medical Technologies, Ltd. has 51.35 million shares outstanding. The public float is 3.98 million shares, elevated short interest at 8.68% of float. This equals 2.07 million shares. The short ratio is 5.01 days. Institutional investors hold 106.63% of the float. Insiders own 5.07%. Webster Brian Daniel holds 349.79 thousand shares, Umberger Traci S has 136.63 thousand shares and COHEN RAYMOND W has 50.90 thousand shares. Over the past six months, insider transactions show net selling. They sold 70.59 thousand shares across 6 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Kestra Medical Technologies generated $59.82M in revenue, or $1.21 per share. Gross margin was 40.47%, operating margin -177.85%, and net profit margin -190.28%. Returns are negative, with ROA at -38.48% and ROE at -55.41%.
On valuation metrics, Kestra Medical Technologies trades at a P/E of -7.45, P/S of 14.25 and P/B of 3.75. The current ratio is 7.32 and quick ratio is 7.32. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -148.95 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.01, supported by a cash flow-to-debt ratio of -20.22.

Quarterly Financial Highlights

Gross profit was $24.21M (margin 40.47%). Operating income was - $106.38M (margin -177.8%). Net income was- $113.81M (EPS - $5.13).
The company ended the quarter with $237.60M in cash and short-term investments, a total debt of $44.31M, and net debt of - $193.28M. Total assets were $295.74M, with equity of $205.41M. Financials further reflected weakness, with operating cash flow of - $77.61M, free cash flow of - $101.20M, and capital expenditures of - $23.59M.

Price Forecast & Outlook

Our AI price prediction model suggests that Kestra Medical Technologies, Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.32%, with price expected at $21.27 by May 29, 2026, within a range of $19.72 to $22.80 3-Month Outlook: Projected fall of -25.38%, reaching $14.79 by August 12, 2026, with a range of $14.36 to $15.20. 1-Year Outlook: Projected gain of 48.28%, with price at $29.39 by May 14, 2027, within a range of $28.16 to $30.69.

Key Takeaways

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) shares are down -13.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Kestra Medical Technologies, Ltd. trading at a premium to the broader market with a P/E of -7.45. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $27.93, suggesting 40.92% upside. Our AI forecast model points to short-term strength (7.32% over two weeks), a medium-term fall (-25.38% over three months), and a longer-term gain (48.28% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Kestra Medical Technologies, Ltd. (KMTS) stock price?

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) stock price is $19.82 in the last trading session. During the trading session, KMTS stock reached the peak price of $21.78 while $19.79 was the lowest point it dropped to. The percentage change in KMTS stock occurred in the recent session was -10.19% while the dollar amount for the price change in KMTS stock was - $2.25.

KMTS's industry and sector of operation?

The NASDAQ listed KMTS is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Kestra Medical Technologies, Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KMTS?

No Data

How KMTS did perform over past 52-week?

KMTS's closing price is 49.59% higher than its 52-week low of $13.25 where as its distance from 52-week high of $30.00 is -33.93%.

How many employees does KMTS have?

Number of KMTS employees currently stands at 300.

Link for KMTS official website?

Official Website of KMTS is: https://kestramedical.com

How do I contact KMTS?

KMTS could be contacted at phone 425 279 8002 and can also be accessed through its website. KMTS operates from 3933 Lake Washington Blvd NE, Kirkland, WA 98033, United States.

How many shares of KMTS are traded daily?

KMTS stock volume for the day was 329.13K shares. The average number of KMTS shares traded daily for last 3 months was 354.97K.

What is the market cap of KMTS currently?

The market value of KMTS currently stands at $1.16B with its latest stock price at $19.82 and 58.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	300
Beta	0.17
Sales or Revenue	$59.82M
5Y Sales Change%	0%
Fiscal Year Ends	April
Sector	Healthcare
Industry	Medical - Instruments & Supplies

KMTS Company Profile and Key Details

Kestra Medical Technologies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Price Forecast & Outlook

Company Overview

Key Takeaways

Valuation Metrics